The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats
- PMID: 25505575
- PMCID: PMC4186398
- DOI: 10.1002/prp2.15
The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats
Abstract
Background: Imatinib (Imb) is a tyrosine kinase inhibitor with cardiotoxic activity (decreases in left ventricular function and congestive heart failure) in patients. Currently, clinical diagnosis of Imb cardiotoxicity relies primarily on evaluation of left ventricular function, Imb also induces cardiac lesions in rats.
Aims: This study, in rats, sought to determine whether monitoring biochemical markers would be a sensitive means to detect Imb-induced changes in cardiomyocyte morphology.
Materials and methods: Groups of male Sprague-Dawley rats were dosed orally with 50, 100, 200 mg kg(-1) Imb or water daily for 28 days. Tissues and blood samples were collected 24 h after the last dosing. Cardiac biomarkers such as cardiac troponin I (cTnI), cardiac troponin T (cTnT), and fatty acid binding protein 3 (FABP3) were monitored by the Erenna, Elecsys, and Meso Scale immunoassay systems.
Results: Imb caused microscopic myocardial lesions (myofibrillar loss, cytoplasmic vacuolization, and necrosis) at all doses as determined by unbiased histopathology analysis. The severity of the alterations was dose-related with mean lesion scores (based on a scale of 0-3) of 1.2 (50 mg kg(-1)), 2.1 (100 mg kg(-1)) and 2.9 (200 mg kg(-1)). However, the increases in cTnI, cTnT, and FABP3 levels were noted primarily in high-dose Imb treated animals.
Discussion and conclusion: The occurrence of myocardial alterations in animals without consistent changes in cardiac troponin and FABP3 concentrations raises questions regarding the utility of these biomarkers as early indicators of Imb-induced cardiotoxicity. Due to limited numbers of animals the reasons for this discrepancy could not be determined.
Keywords: Cardiac biomarkers; Imatinib cardiotoxicity; rats.
Figures

Similar articles
-
A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat.Toxicol Pathol. 2011 Dec;39(7):1091-106. doi: 10.1177/0192623311419524. Epub 2011 Sep 21. Toxicol Pathol. 2011. PMID: 21937741
-
Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats.Toxicology. 2009 Dec 21;266(1-3):48-54. doi: 10.1016/j.tox.2009.10.014. Epub 2009 Oct 23. Toxicology. 2009. PMID: 19854236
-
Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat.Toxicol Pathol. 2010 Aug;38(5):703-14. doi: 10.1177/0192623310374969. Epub 2010 Jun 28. Toxicol Pathol. 2010. PMID: 20585145
-
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.J Clin Oncol. 1999 Jul;17(7):2237-43. doi: 10.1200/JCO.1999.17.7.2237. J Clin Oncol. 1999. PMID: 10561281
-
Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity.Toxicology. 2008 Mar 20;245(3):206-18. doi: 10.1016/j.tox.2007.12.006. Epub 2007 Dec 17. Toxicology. 2008. PMID: 18249481 Review.
Cited by
-
Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction.Cardiovasc Res. 2023 May 2;119(3):710-728. doi: 10.1093/cvr/cvac087. Cardiovasc Res. 2023. PMID: 35640873 Free PMC article. Review.
-
Multiplex biomarker approach to cardiovascular diseases.Acta Pharmacol Sin. 2018 Jul;39(7):1068-1072. doi: 10.1038/aps.2018.29. Epub 2018 Apr 12. Acta Pharmacol Sin. 2018. PMID: 29645001 Free PMC article. Review.
-
Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy.Cureus. 2023 Nov 30;15(11):e49696. doi: 10.7759/cureus.49696. eCollection 2023 Nov. Cureus. 2023. PMID: 38033434 Free PMC article. Review.
References
-
- Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol. 2009;10:391–399. - PubMed
-
- Billingham ME. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In: Silver MD, editor. Cardiovascular pathology. Vol. 2. New York, NY: Churchill Livingstone; 1991. pp. 1465–1486.
-
- Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 2004;109:2749–2754. - PubMed
-
- Cardinale D, Colombo A, Torrisi R, Sandri MT, Civelli M, Salvatici M, et al. Traztuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol. 2010;28:3910–3916. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous